Cargando…
Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
BACKGROUND: Resistance to apoptosis induced by anti-cancer drugs is a major obstacle for the treatment of aggressive forms of breast cancer. Galectin-7 (gal-7) was recently shown to be specifically expressed in basal-like but not in luminal subtypes of human breast cancer. METHODS: We generated a mu...
Autores principales: | Grosset, Andrée-Anne, Labrie, Marilyne, Gagné, Donald, Vladoiu, Maria-Claudia, Gaboury, Louis, Doucet, Nicolas, St-Pierre, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228062/ https://www.ncbi.nlm.nih.gov/pubmed/25367122 http://dx.doi.org/10.1186/1471-2407-14-801 |
Ejemplares similares
-
Expression and functions of galectin-7 in ovarian cancer
por: Labrie, Marilyne, et al.
Publicado: (2014) -
A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer
por: Labrie, Marilyne, et al.
Publicado: (2015) -
Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
por: Grosset, Andrée-Anne, et al.
Publicado: (2016) -
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
por: Vladoiu, Maria Claudia, et al.
Publicado: (2015) -
Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)